Prva.Bo

Opportunity

Upcoming catalysts

Pre-earnings brief

Privia Health Group Inc (PRVA.O) is undergoing its first formal analysis, establishing a baseline for future performance tracking. As this is the initial assessment for the ticker, there is no prior data available to compute material changes or deltas in financial metrics or operational performance. The most significant recent activity involves a major modification in holder positions for investor ID 587. Data detected on June 23, 2026, indicates that this investor’s holding increased to 10,345 shares, valued at approximately $0.21 million, representing a portfolio weight of 0.00012%. This contrasts with a prior state recorded on the same date, March 31, 2026, where the holding was significantly lower at 16 shares. A subsequent signal detected on June 21, 2026, reflects a reversal or correction in this data, showing the investor’s position returning to 16 shares, valued at roughly $0.0003 million. These conflicting signals regarding the same investor’s share count on the same reporting date highlight volatility or data reconciliation issues in the ownership records rather than a clear, sustained shift in institutional sentiment. Privia Health Group currently has no analyst coverage, no index memberships, and no reported officers in the available data, though it maintains 30 top holders. The absence of analyst estimates or ESG ratings further underscores the limited market scrutiny and data availability for the company at this stage.

Signals & dispatch

Composite-score breakdown

Synthesis

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Sell-side observations

Themes

ESG

Risk factors

• Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Derivative transactions

• Mountcastle DavidEVP & Chief Financial Officer · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 202 @ $2,00exercise · 2026-05-04
• Mountcastle DavidEVP & Chief Financial Officer · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 52 @ $2,00exercise · 2026-05-04
• Mountcastle DavidEVP & Chief Financial Officer · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 592 @ $2,00exercise · 2026-05-04
• Mountcastle DavidEVP & Chief Financial Officer · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 360 @ $2,00exercise · 2026-05-04
• Morris Matthew ShawnDirector · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 1 017 @ $2,00exercise · 2026-05-04
• Mountcastle DavidEVP & Chief Financial Officer · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 3 010 @ $2,00exercise · 2026-05-01
• Mountcastle DavidEVP & Chief Financial Officer · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 1 297 @ $2,00exercise · 2026-05-01
• Mountcastle DavidEVP & Chief Financial Officer · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 541 @ $2,00exercise · 2026-05-01
• Morris Matthew ShawnDirector · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 17 096 @ $2,00exercise · 2026-05-01
• Mountcastle DavidEVP & Chief Financial Officer · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 2 331 @ $2,00exercise · 2026-05-01
• Morris Matthew ShawnDirector · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 16 550 @ $2,00exercise · 2026-02-27
• Morris Matthew ShawnDirector · Stock Option (Right to Purchase) → Common Stock, par value $0.01 per shareDisposed 7 788 @ $2,00exercise · 2026-02-26

Actions

Ask Handelsavisen